221 related articles for article (PubMed ID: 21521028)
1. Novel sensitive, specific and rapid pharmacogenomic test for the prediction of abacavir hypersensitivity reaction: HLA-B*57:01 detection by real-time PCR.
Dello Russo C; Lisi L; Lofaro A; Di Giambenedetto S; Federico B; Madeddu G; Salerno M; Mura MS; Pirazzoli A; de Luca A; Cauda R; Navarra P
Pharmacogenomics; 2011 Apr; 12(4):567-76. PubMed ID: 21521028
[TBL] [Abstract][Full Text] [Related]
2. Human leukocyte antigen (HLA) and pharmacogenetics: screening for HLA-B*57:01 among human immunodeficiency virus-positive patients from southern Alberta.
Berka N; Gill JM; Liacini A; O'Bryan T; Khan FM
Hum Immunol; 2012 Feb; 73(2):164-7. PubMed ID: 22197535
[TBL] [Abstract][Full Text] [Related]
3. External quality assessment of HLA-B*5701 reporting: an international multicentre survey.
Hammond E; Almeida CA; Mamotte C; Nolan D; Phillips E; Schollaardt TA; Gill MJ; Angel JB; Neurath D; Li J; Giulivi T; McIntyre C; Koultchitski G; Wong B; Reis M; Rachlis A; Cole DE; Chew CB; Neifer S; Lalonde R; Roger M; Jeanneau A; Mallal S
Antivir Ther; 2007; 12(7):1027-32. PubMed ID: 18018760
[TBL] [Abstract][Full Text] [Related]
4. HLA-B*5701 screening for hypersensitivity to abacavir.
Mallal S; Phillips E; Carosi G; Molina JM; Workman C; Tomazic J; Jägel-Guedes E; Rugina S; Kozyrev O; Cid JF; Hay P; Nolan D; Hughes S; Hughes A; Ryan S; Fitch N; Thorborn D; Benbow A;
N Engl J Med; 2008 Feb; 358(6):568-79. PubMed ID: 18256392
[TBL] [Abstract][Full Text] [Related]
5. Incidence of abacavir hypersensitivity and its relationship with HLA-B*5701 in HIV-infected patients in Taiwan.
Sun HY; Hung CC; Lin PH; Chang SF; Yang CY; Chang SY; Chang SC
J Antimicrob Chemother; 2007 Sep; 60(3):599-604. PubMed ID: 17631508
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of HLA-B*57:01 screening for the prediction of abacavir hypersensitivity and clinical utility of the test: a meta-analytic review.
Cargnin S; Jommi C; Canonico PL; Genazzani AA; Terrazzino S
Pharmacogenomics; 2014 May; 15(7):963-76. PubMed ID: 24956250
[TBL] [Abstract][Full Text] [Related]
7. Studies on abacavir-induced hypersensitivity reaction: a successful example of translation of pharmacogenetics to personalized medicine.
Guo Y; Shi L; Hong H; Su Z; Fuscoe J; Ning B
Sci China Life Sci; 2013 Feb; 56(2):119-24. PubMed ID: 23393027
[TBL] [Abstract][Full Text] [Related]
8. A sensitive and rapid alternative to HLA typing as a genetic screening test for abacavir hypersensitivity syndrome.
Martin AM; Krueger R; Almeida CA; Nolan D; Phillips E; Mallal S
Pharmacogenet Genomics; 2006 May; 16(5):353-7. PubMed ID: 16609367
[TBL] [Abstract][Full Text] [Related]
9. A simple screening approach to reduce B*5701-associated abacavir hypersensitivity on the basis of sequence variation in HIV reverse transcriptase.
Chui CK; Brumme ZL; Brumme CJ; Yip B; Phillips EJ; Montaner JS; Harrigan PR
Clin Infect Dis; 2007 Jun; 44(11):1503-8. PubMed ID: 17479950
[TBL] [Abstract][Full Text] [Related]
10. Should HLA-B*5701 screening be performed in every ethnic group before starting abacavir?
Park WB; Choe PG; Song KH; Lee S; Jang HC; Jeon JH; Park SW; Park MH; Oh MD; Choe KW
Clin Infect Dis; 2009 Feb; 48(3):365-7. PubMed ID: 19115972
[TBL] [Abstract][Full Text] [Related]
11. HLA- B*5701 Allele in HIV-infected Indian Children and its Association with Abacavir Hypersensitivity.
Manglani MV; Gabhale YR; Lala MM; Sekhar R; More D
Indian Pediatr; 2018 Feb; 55(2):140-141. PubMed ID: 29242412
[TBL] [Abstract][Full Text] [Related]
12. HLA-B*5701 screening for susceptibility to abacavir hypersensitivity.
Lucas A; Nolan D; Mallal S
J Antimicrob Chemother; 2007 Apr; 59(4):591-3. PubMed ID: 17317695
[TBL] [Abstract][Full Text] [Related]
13. HLA-B*5701 typing: evaluation of an allele-specific polymerase chain reaction melting assay.
Hammond E; Mamotte C; Nolan D; Mallal S
Tissue Antigens; 2007 Jul; 70(1):58-61. PubMed ID: 17559582
[TBL] [Abstract][Full Text] [Related]
14. Comparative Analysis of Real-Time Polymerase Chain Reaction Methods to Typing HLA-B*57:01 in HIV-1-Positive Patients.
Falasca F; Dello Russo C; Mora B; Pirazzoli A; Fantauzzi A; Navarra P; Pizzuti A; De Vito C; Antonelli G; Turriziani O
AIDS Res Hum Retroviruses; 2016 Jul; 32(7):654-7. PubMed ID: 26750774
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of HLA-B*57:01 allele in Argentinean HIV-1 infected patients.
Moragas M; Belloso WH; Baquedano MS; Gutierrez MI; Bissio E; Larriba JM; Fay F; Aulicino P; Gurevich JM; Yaunguzian MF; Maldonado AC; Falistocco C; Sen L; Mangano A
Tissue Antigens; 2015 Jul; 86(1):28-31. PubMed ID: 25922880
[TBL] [Abstract][Full Text] [Related]
16. Abacavir adverse reactions related with HLA-B*57: 01 haplotype in a large cohort of patients infected with HIV.
Quiros-Roldan E; Gardini G; Properzi M; Ferraresi A; Carella G; Marchi A; Malagoli A; Focà E; Castelli F
Pharmacogenet Genomics; 2020 Oct; 30(8):167-174. PubMed ID: 32453265
[TBL] [Abstract][Full Text] [Related]
17. Refining abacavir hypersensitivity diagnoses using a structured clinical assessment and genetic testing in the Swiss HIV Cohort Study.
Rauch A; Nolan D; Thurnheer C; Fux CA; Cavassini M; Chave JP; Opravil M; Phillips E; Mallal S; Furrer H;
Antivir Ther; 2008; 13(8):1019-28. PubMed ID: 19195327
[TBL] [Abstract][Full Text] [Related]
18. Prospective genetic screening decreases the incidence of abacavir hypersensitivity reactions in the Western Australian HIV cohort study.
Rauch A; Nolan D; Martin A; McKinnon E; Almeida C; Mallal S
Clin Infect Dis; 2006 Jul; 43(1):99-102. PubMed ID: 16758424
[TBL] [Abstract][Full Text] [Related]
19. HLA-B*5701 frequency in Chilean HIV-infected patients and in general population.
Poggi H; Vera A; Lagos M; Solari S; Rodríguez P L; Pérez CM
Braz J Infect Dis; 2010; 14(5):510-2. PubMed ID: 21221482
[TBL] [Abstract][Full Text] [Related]
20. Current trends in screening across ethnicities for hypersensitivity to abacavir.
Rodriguez-Nóvoa S; Soriano V
Pharmacogenomics; 2008 Oct; 9(10):1531-41. PubMed ID: 18855539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]